Author

Nathakan Thongon

The University of Texas MD Anderson Cancer CenterORCID 0000-0002-6169-403XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

Adam PickardiD· 1 shared Ágata Sofia Assunção CarreiraiD· 1 shared Alessandro ProvenzaniiD· 1 shared Alessio NencioniiD· 1 shared Alexey V. RevtovichiD· 1 shared Andrea LunardiiD· 1 shared Bernadetta Meika· 1 shared Charles M. Haughey· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adam PickardORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cheminformatic identification of small molecules targeting acute myeloid leukemia

Megan R. Daneman, Bernadetta Meika, Lois Armendariz, Elissa Tjahjono, Alexey V. Revtovich, Leonid A. Stolbov, Natthakan Thongon, Natalia Baran, Scott R. Gilbertson, Vladimir Poroikov, Natalia V. Kirienko

The paper identifies small molecules targeting AML by screening for compounds with predicted functions in apoptosis, glutathione metabolism, and autophagy, validating their efficacy in AML cells and patient-derived samples.

Leukemia · Aug 27, 2026Peer-reviewedCancer Biology

NNMT drives innate sensitivity to NAMPT inhibition in YAP-dependent stem-like/ mesenchymal prostate cancer

Ágata Sofia Assunção Carreira, Marianna Ciuffreda, Nathakan Thongon, Charles M. Haughey, Adam Pickard, Sharon L. Eddie, Rebecca E. Steele, Elena Cerri, Romina Belli, Daniele Peroni, Elisa Facen, Irene Caffa, Moustafa S. Ghanem, Alessio Nencioni, Andrea Lunardi, , Alessandro Provenzani

This study identifies the YAP/NNMT axis as a driver of innate sensitivity to NAMPT inhibition in stem-like mesenchymal prostate cancer, suggesting NNMT as a biomarker for NAD+-targeting therapies.

International Journal of Biological Sciences · Jan 1, 2026Peer-reviewedCancer Biology